The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes
- PMID: 34851413
- PMCID: PMC9258424
- DOI: 10.1542/peds.2021-051910
The Childhood Vaccination Schedule and the Lack of Association With Type 1 Diabetes
Abstract
Objectives: Safety studies assessing the association between the entire recommended childhood immunization schedule and autoimmune diseases, such as type 1 diabetes mellitus (T1DM), are lacking. To examine the association between the recommended immunization schedule and T1DM, we conducted a retrospective cohort study of children born between 2004 and 2014 in 8 US health care organizations that participate in the Vaccine Safety Datalink.
Methods: Three measures of the immunization schedule were assessed: average days undervaccinated (ADU), cumulative antigen exposure, and cumulative aluminum exposure. T1DM incidence was identified by International Classification of Disease codes. Cox proportional hazards models were used to analyze associations between the 3 exposure measures and T1DM incidence. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) were calculated. Models were adjusted for sex, race and ethnicity, birth year, mother's age, birth weight, gestational age, number of well-child visits, and study site.
Results: In a cohort of 584 171 children, the mean ADU was 38 days, the mean cumulative antigen exposure was 263 antigens (SD = 54), and the mean cumulative aluminum exposure was 4.11 mg (SD = 0.73). There were 1132 incident cases of T1DM. ADU (aHR = 1.01; 95% CI, 0.99-1.02) and cumulative antigen exposure (aHR = 0.98; 95% CI, 0.97-1.00) were not associated with T1DM. Cumulative aluminum exposure >3.00 mg was inversely associated with T1DM (aHR = 0.77; 95% CI, 0.60-0.99).
Conclusions: The recommended schedule is not positively associated with the incidence of T1DM in children. These results support the safety of the recommended childhood immunization schedule.
Copyright © 2021 by the American Academy of Pediatrics.
Conflict of interest statement
POTENTIAL CONFLICT OF INTEREST: Dr Klein receives research support from Pfizer, Merck, Sanofi Pasteur, GlaxoSmithKline, and Protein Science (now Sanofi Pasteur). All other authors have indicated they have no potential conflicts of interest to disclose.
Figures
![FIGURE 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9258424/bin/nihms-1818111-f0001.gif)
![FIGURE 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/9258424/bin/nihms-1818111-f0002.gif)
Similar articles
-
Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months.Acad Pediatr. 2023 Jan-Feb;23(1):37-46. doi: 10.1016/j.acap.2022.08.006. Epub 2022 Sep 28. Acad Pediatr. 2023. PMID: 36180331 Free PMC article.
-
Association Between Rotavirus Vaccination and Type 1 Diabetes in Children.JAMA Pediatr. 2020 May 1;174(5):455-462. doi: 10.1001/jamapediatrics.2019.6324. JAMA Pediatr. 2020. PMID: 32150236 Free PMC article.
-
A combination vaccine against measles, mumps, rubella and varicella.Drugs Today (Barc). 2008 Apr;44(4):279-92. doi: 10.1358/dot.2008.44.4.1210755. Drugs Today (Barc). 2008. PMID: 18536786 Review.
-
Clustering of cases of type 1 diabetes mellitus occurring 2-4 years after vaccination is consistent with clustering after infections and progression to type 1 diabetes mellitus in autoantibody positive individuals.J Pediatr Endocrinol Metab. 2003 Apr-May;16(4):495-508. doi: 10.1515/jpem.2003.16.4.495. J Pediatr Endocrinol Metab. 2003. PMID: 12793601 Review.
-
Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus.Pediatrics. 2001 Dec;108(6):E112. doi: 10.1542/peds.108.6.e112. Pediatrics. 2001. PMID: 11731639
Cited by
-
Association Between Aluminum Exposure From Vaccines Before Age 24 Months and Persistent Asthma at Age 24 to 59 Months.Acad Pediatr. 2023 Jan-Feb;23(1):37-46. doi: 10.1016/j.acap.2022.08.006. Epub 2022 Sep 28. Acad Pediatr. 2023. PMID: 36180331 Free PMC article.
-
Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children - From Disease Pathogenesis to Complications.Front Endocrinol (Lausanne). 2022 Jun 16;13:890833. doi: 10.3389/fendo.2022.890833. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35784568 Free PMC article. Review.
-
Providers' Attitudes to Proposed Changes in the Critical Congenital Heart Disease Screening Algorithm.Pediatr Cardiol. 2022 Aug;43(6):1354-1358. doi: 10.1007/s00246-022-02858-4. Epub 2022 Mar 4. Pediatr Cardiol. 2022. PMID: 35244731
References
-
- Centers for Disease Control and Prevention. Ten great public health achievements—United States, 2001–2010. MMWR Morb Mortal Wkly Rep. 2011;60(19):619–623 - PubMed
-
- Almawi WY, Tamim H, Azar ST. Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. J Clin Endocrinol Metab. 1999;84(5):1497–1502 - PubMed
-
- DeStefano F, Bodenstab HM, Offit PA. Principal controversies in vaccine safety in the United States. Clin Infect Dis. 2019;69(4):726–731 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical